ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Aridis Pharmaceuticals COVID mAb AR-712 Neutralizes SARS-CoV-2 Delta Variant
July 13, 2021Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) announced today that its COVID-19 mAb cocktail AR-712 binds and neutralizes the Delta variant virus SARS-CoV-2 at a highly effective level (~20ng/mL). -
Aridis Pharmaceuticals Receives Orphan Drug Designation for AR-501
June 28, 2019Aridis Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to AR-501, the Company's inhaled formulation of gallium citrate for treatment of lung infection in patients with cystic fibrosis.
Pharma Sources Insight January 2025
